O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1278-1287

  Lieberthal, Wilfred ^a,b   Fuhro, Robert ^a   Freedman, Jane E ^a   Toolan, George ^a   Loscalzo, Joseph ^a   Valeri, C Robert ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; HEMOGLOBIN; HEMOGLOBIN A; NITRIC OXIDE; RAFFINOSE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CROSS LINKING; EXCHANGE BLOOD TRANSFUSION; HEART OUTPUT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; RESISTANCE BLOOD VESSEL;

ANIMALS; ELECTROLYTES; EXCHANGE TRANSFUSION, WHOLE BLOOD; HEMATOCRIT; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HUMANS; KIDNEY; MALE; NITRIC OXIDE; RAFFINOSE; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION;

EID: 0032984832     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Adamson JG and Moore C (1998) Hemolink™, an O-raffinose cross-linked hemoglobin-based oxygen carrier, in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Chang TMS ed), vol 2, pp 62-81, Kargee Landes Systems, New York.
2. Asakura T and Reilly M (1986) Methods for the measurement of oxygen equilibration curves of red cell suspensions and hemoglobin solutions: Advances in the biosciences, in Oxygen Transport in Red Blood Cells (Nicolau EC ed) vol 54, pp 57-75, Pergamon Press, New York.
3. Baines AD, Christoff B, Wicks D, Wiffen D and Pliura D (1995) Cross-linked hemoglobin increases fractional reabsorption and GFR in hypoxic isolated perfused rat kidneys. Am J Physiol 269:F628-F636.
4. Baylis C, Harton P and Engels K (1990) Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1:875-881.
5. Benesch R and Benesch R (1961) Preparation and properties of hemoglobin modified with derivatives of pyridoxyl. Methods Enzymol 76:147-158.
6. Blakney GB and Dinwoodie AJ (1975) A spectrophotometric scanning technique for the rapid determination of plasma hemoglobin. Clin Biochem 8:96-102.
7. Born G and Cross M (1963) The aggregation of blood platelets. J Physiol (London) 168:178-195.
8. Bunn HF, Esham WT and Bull RW (1969) The renal handling of hemoglobin. I. Glomerular filtration. J Exp Med 129:909-923.
9. Chang T (1997) Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red cell substitutes. Biomater Artif Cells Immob Biotech 25:1-24.
10. Doherty DH, Doyle MP, Curry SR, Vall RJ, Fattor TJ, Olson JS and Lemon DD (1998) Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nature Biotech 16:672-676.
11. Freedman JE, Fabian A and Loscalzo J (1995) Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP. Am J Physiol 268:C520-C526.
12. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF and Michelson AD (1997) Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 100:350-356.
13. Hess JR, MacDonald VW and Brinkley WW (1993) Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 74:1769-1778.
14. Hsia JC (1991) O-raffinose polymerized hemoglobin as a red cell substitute. Biomater Artif Cells Immob Biotech 19:402-405.
15. Ichimori K, Ishida H, Fukahori M, Nakazawa H and Murakami E (1994) Practical nitric oxide measurement employing a nitric oxide-selective electrode. Rev Sci Instrum 65:1-5.
16. Iwamoto J and Morin FC (1993) Nitric oxide inhibition varies with hemoglobin saturation. J Appl Physiol 75:2332-2336.
17. Jaenike JR (1967) The renal lesion associated with hemoglobinemia: A study of the pathogenesis of the excretory defect in the rat. J Clin Invest 46:378-387.
18. Jia L, Bonaventura C, Bonaventura J and Stamler JS (1996) S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature (London) 380:211-226.
19. Kasper SM, Walter M, Grne F, Bischoff A, Erasmi H and Buzello W (1996) Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 83:921-927.
20. Kilbourn RG, Joly G, Cashon B, DeAngelo J and Bonaventura J (1994) Cell-free hemoglobin reverses the endotoxin mediated hyporesponsivity of rat aortic rings to alpha-adrenergic agents. Biochem Biophys Res Commun 199:155-162.
21. Lieberthal W (1995) Stroma-free hemoglobin: A potential blood substitute. J Lab Clin Med 126:231-232.
22. Lieberthal W (1997) Renal effects of hemoglobin-based blood substitutes, in Red Blood Cell Substitutes (Rudolph A, Rabinovici R and Feuerstein G eds) pp 189-218, Marcel Dekker, New York.
23. Lieberthal W, McGarry AE, Sheils J and Valeri C (1991) Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock. Am J Physiol 261:F868-F872.
24. Lieberthal W, Wolf EF, Merrill EW, Levinsky NG and Valeri CR (1987) Hemodynamic effects of different preparations of stroma free hemolysates in the isolated perfused rat kidney. Life Sci 41:2525-2533.
25. Loscalzo J (1985) N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest 76:703-708.
26. Martin W, Smith JA and White DG (1986) The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol 89:563-571.
27. Mendelsohn ME, O'Neill S, George D and Loscalzo J (1990) Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 265: 19028-19034.
28. Motterlini R, Vandegriff KD and Winslow RM (1996) Hemoglobin-nitric oxide interaction and its implications. Transfusion Med Rev 10:77-84.
29. Paller MS (1988) Hemoglobin-and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am J Physiol 255:F539-F544.
30. Palmer RM, Ferrige AG and Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 327: 524-526.
31. Pradelles P, Grassi J, Chabardes D and Guiso N (1989) Enzyme immunoassays of adenosine cyclic 3,5-monophosphate and guanosine cyclic 3,5-monophosphate using acetylcholinesterase. Anal Chem 61:447-453.
32. Rabiner SF, Helbert JR, Lopas H and Friedman LH (1967) Evaluation of a stroma-free hemoglobin for use as a plasma expander. J Exp Med 126:1127-1142.
33. Rifkind JM, Zhang L, Heim JM and Levy A (1988) The role of hemoglobin in generating oxyradicals. Basic Life Sci 49:157-162.
34. Rohlfs RJ, Bruner E, Chiu A, Gonzales A, Magde D, Magde MD, Vandegriff KD and Winslow RM (1998) Arterial blood responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 273:12128-12134.
35. Savitsky JP, Doczi J, Black J and Arnold J (1978) A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 23:73-80.
36. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K and Malcolm DS (1993) A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122:301-308.
37. Thompson A, McGarry AE, Valeri CR and Lieberthal W (1994) Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J Appl Physiol 77:2348-2354.
38. Thompson A, Valeri C and Lieberthal W (1995) Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am J Physiol 269:H743-H748.
39. Vogel WM, Dennis RC, Cassidy G, Apstein CS and Valeri CR (1986) Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol 251:H413-H420.
40. Wennmalm A, Benthin G and Petersson AS (1992) Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 106:507-508.
41. Winterbourn CC (1990) Oxidative reactions of hemoglobin. Methods Enzymol 186: 265-272.
42. Zager RA and Gamelin LM (1989) Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Physiol 256:F446-F455.